{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -0.5235613, "regularMarketPrice": 0.38, "currency": "EUR", "exchange": "FRA", "shortName": "GEMINA LABS LTD", "longName": "Gemina Laboratories Ltd.", "messageBoardId": "finmb_710756480", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "marketState": "REGULAR", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1630389600000, "priceHint": 4, "regularMarketChange": -0.002000004, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.38, "regularMarketDayRange": "0.38 - 0.38", "regularMarketDayLow": 0.38, "regularMarketVolume": 4000, "regularMarketPreviousClose": 0.382, "bid": 0.38, "ask": 0.464, "fullExchangeName": "Frankfurt", "financialCurrency": "CAD", "regularMarketOpen": 0.38, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.168, "fiftyTwoWeekLowChangePercent": 0.7924528, "fiftyTwoWeekRange": "0.212 - 0.472", "fiftyTwoWeekHighChange": -0.09200001, "fiftyTwoWeekHighChangePercent": -0.19491526, "fiftyTwoWeekLow": 0.212, "fiftyTwoWeekHigh": 0.472, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.06, "sharesOutstanding": 67572304, "bookValue": 0.016, "fiftyDayAverage": 0.40012, "fiftyDayAverageChange": -0.020119995, "fiftyDayAverageChangePercent": -0.050284903, "twoHundredDayAverage": 0.32238, "twoHundredDayAverageChange": 0.05761999, "twoHundredDayAverageChangePercent": 0.17873314, "marketCap": 28102708, "priceToBook": 23.749998, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "symbol": "8I7.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3600 Gilmore Way", "address2": "Suite 302", "city": "Burnaby", "state": "BC", "zip": "V5G 4R9", "country": "Canada", "website": "https://www.geminalabs.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. It is developing platforms for the rapid testing of COVID-19, influenza, and other viruses. The company is headquartered in Burnaby, Canada.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Brian  Firth", "title": "CEO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert  Porter", "title": "Pres & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Liggett B.Sc., Bsc. Pharm., C.A., C.P.A., CA, CPA", "age": 62, "title": "CFO & Company Sec.", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Robert Crandall Greene", "title": "CTO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hugh  McNaught", "title": "VP of Marketing & Member of Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David  Browning FCIM, M.Sc.", "title": "Head of Productization & Director of Gemina Laboratories (UK) Limited", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christine  Buerki Ph.D.", "title": "Head of Product Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}